Mitchell Glass

Mitchell Glass is currently Chief Executive Officer & Director at Chronic Airway Therapeutics Pty Ltd., Chairman at Accolade Pharma LLC, Director at Orphagenix, Inc., Director at Avatar Biotechnologies LLC, and Director & Chief Medical Officer at Q.
Former roles include Chief Executive Officer at Aqumen Biopharmaceuticals KK, Chief Executive Officer at Aqumen Biopharmaceuticals NA, Inc., Director & Vice President at GlaxoSmithKline LLC, Executive Director & Chief Medical Officer at Invion Ltd., Chief Medical Officer & VP-Regulatory Affairs at AtheroGenics, Inc., Principal at the University of Pennsylvania, Chief Scientific Officer at University City Science Center, Principal at AstraZeneca, Inc., Principal at Inverseon, Inc., and Chief Medical Officer & EVP-Research & Development at Invion Ltd. Education includes undergraduate and doctorate degrees from The University of Chicago, conferred in 1973 and 1977 respectively.